medroxyprogesterone acetate has been researched along with Retroperitoneal Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baltar Arias, R; Castro Ortiz, E; Fernández Salgado, E; Ibáñez Pinto, A; Ledo Barro, L; Vázquez Astray, E; Vázquez San Luis, J; Vázquez Vázquez, S | 1 |
1 review(s) available for medroxyprogesterone acetate and Retroperitoneal Neoplasms
Article | Year |
---|---|
[Gastrointestinal bleeding of obscure origin caused by a metastatic endometrial adenocarcinoma. Response to hormonal therapy].
Topics: Aged; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Combined Modality Therapy; Endometrial Neoplasms; Female; Gastrointestinal Hemorrhage; Humans; Lymphatic Metastasis; Medroxyprogesterone Acetate; Pelvic Neoplasms; Peritoneal Neoplasms; Retroperitoneal Neoplasms; Tomography, X-Ray Computed; Umbilicus | 2007 |